Neuromodulation : journal of the International Neuromodulation Society · 2012
Treatment of multifocal pain with spinal cord stimulation.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yakovlev Alexander E, Resch Beth E
Аннотация
INTRODUCTION: We report a retrospective case study of combined treatment of cancer-related pain and chronic low back and lower extremity pain related to postlaminectomy syndrome (PLS) with one spinal cord stimulation (SCS) system.
METHODS: The patient underwent an uneventful SCS trial with percutaneous placement of two temporary eight-electrode leads (Medtronic Inc., Minneapolis, MN) placed at the level of T8-T9-T10 and T5-T6-T7.
RESULTS: After successful trial, he was implanted with permanent leads and generator, reporting sustained pain relief at 12-month follow-up visit.
DISCUSSION: SCS is a trialable, reversible, and interactive therapy permitting patients to control the level of stimulation they feel based on their degree of pain.
CONCLUSION: SCS provides an effective, alternative treatment for select patients with cancer-related chest wall pain and pain related to PLS who have failed conservative treatment.
METHODS: The patient underwent an uneventful SCS trial with percutaneous placement of two temporary eight-electrode leads (Medtronic Inc., Minneapolis, MN) placed at the level of T8-T9-T10 and T5-T6-T7.
RESULTS: After successful trial, he was implanted with permanent leads and generator, reporting sustained pain relief at 12-month follow-up visit.
DISCUSSION: SCS is a trialable, reversible, and interactive therapy permitting patients to control the level of stimulation they feel based on their degree of pain.
CONCLUSION: SCS provides an effective, alternative treatment for select patients with cancer-related chest wall pain and pain related to PLS who have failed conservative treatment.